Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tze-Peng Lim

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Antimicrobial Agents|November 27, 2015
Intravenous ceftaroline 200 mg administered every 8 h is safe and adequate for meticillin-resistant Staphylococcus aureus bloodstream infections in end-stage renal failure patients on haemodialysis: a case studyShimin J Chung, Tze-Peng Lim, Andrea L Kwa
Current Infectious Disease Reports|April 2, 2008
Pharmacokinetic/Pharmacodynamic antimicrobial individualization and optimization strategiesTze-Peng Lim, Kevin W Garey, Vincent H Tam
Infection Control and Hospital Epidemiology|December 17, 2013
Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source controlAnucha Apisarnthanarak, Li Yang Hsu, Tze-Peng Lim, et al.
ACS Nano|August 6, 2016
Antimicrobial Cluster Bombs: Silver Nanoclusters Packed with DaptomycinKaiyuan Zheng, Magdiel I Setyawati, Tze-Peng Lim, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 2, 2010
Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 degrees CJie He, Deborah A Figueroa, Tze-Peng Lim, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2008
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance developmentVincent H Tam, Kimberly R Ledesma, Giao Vo, et al.
International Journal of Antimicrobial Agents|May 25, 2026
The costs and health outcomes associated with a personalised antibiotic combination testing service for carbapenem-resistant Pseudomonas aeruginosa: a cost-effectiveness analysisYiying Cai, Tze-Peng Lim, Winnie Lee, et al.
Advances in Experimental Medicine and Biology|August 1, 2019
In vitro Pharmacodynamics and PK/PD in AnimalsWinnie Lee, Yiying Cai, Tze-Peng Lim, et al.
Microorganisms|September 30, 2016
Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red DotJocelyn Qi Min Teo, Yiying Cai, Tze-Peng Lim, et al.
Plos One|May 3, 2011
In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in SingaporeTze-Peng Lim, Thean-Yen Tan, Winnie Lee, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Antimicrobial Agents|November 27, 2015
Intravenous ceftaroline 200 mg administered every 8 h is safe and adequate for meticillin-resistant Staphylococcus aureus bloodstream infections in end-stage renal failure patients on haemodialysis: a case studyShimin J Chung, Tze-Peng Lim, Andrea L Kwa
Current Infectious Disease Reports|April 2, 2008
Pharmacokinetic/Pharmacodynamic antimicrobial individualization and optimization strategiesTze-Peng Lim, Kevin W Garey, Vincent H Tam
Infection Control and Hospital Epidemiology|December 17, 2013
Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source controlAnucha Apisarnthanarak, Li Yang Hsu, Tze-Peng Lim, et al.
ACS Nano|August 6, 2016
Antimicrobial Cluster Bombs: Silver Nanoclusters Packed with DaptomycinKaiyuan Zheng, Magdiel I Setyawati, Tze-Peng Lim, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 2, 2010
Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 degrees CJie He, Deborah A Figueroa, Tze-Peng Lim, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2008
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance developmentVincent H Tam, Kimberly R Ledesma, Giao Vo, et al.
International Journal of Antimicrobial Agents|May 25, 2026
The costs and health outcomes associated with a personalised antibiotic combination testing service for carbapenem-resistant Pseudomonas aeruginosa: a cost-effectiveness analysisYiying Cai, Tze-Peng Lim, Winnie Lee, et al.
Advances in Experimental Medicine and Biology|August 1, 2019
In vitro Pharmacodynamics and PK/PD in AnimalsWinnie Lee, Yiying Cai, Tze-Peng Lim, et al.
Microorganisms|September 30, 2016
Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red DotJocelyn Qi Min Teo, Yiying Cai, Tze-Peng Lim, et al.
Plos One|May 3, 2011
In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in SingaporeTze-Peng Lim, Thean-Yen Tan, Winnie Lee, et al.
Pageof 7